🔎 Trials Near Me

መነሻ › የክሮን በሽታ › ኢንዲያና › Indianapolis

በIndianapolis፣ IN ለየክሮን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለየክሮን በሽታ የሚደረጉ 10 ጥናቶች በIndianapolis እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Indiana University Health University Hospital ( Site 5022), Indianapolis
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Indiana University Health University Hospital /ID# 278129, Indianapolis
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06548542

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Riley Hospital for Children, Indianapolis
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • IU Health University Hospital, Indianapolis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Indiana University Health University Hospital, Indianapolis
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Riley Childrens Hospital, Indianapolis
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Riley Hospital for Children at Indiana University Health, Indianapolis
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Riley Hospital for Children, Indianapolis
እድሜ ከ6 እስከ 22 · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT05660746

በሌሎች ከተሞች ለየክሮን በሽታ የሚደረጉ ጥናቶች

በIndianapolis ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።